Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

21.31 -1.15 (-5.12%)

Streaming Delayed Price Updated: 2:00 PM EDT, Mar 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

53 54 Next >

Hims & Hers Stock: More Gains Ahead Or A Pullback? Most Retail Traders Bet On This Path ↗

February 18, 2025

A poll of over 4,000 respondents found that 47% believe the stock will continue its climb past $60, while 44% expect a significant pullback for profit-taking.

Via Stocktwits

Novo Nordisk Shares Near New 52-Week Low: Analysts See Big Upside

February 17, 2025

Novo Nordisk shares are closing in on a new 52-week low. Is the stock gearing up for a recovery with sentiment currently low?

Via MarketBeat

Super Micro Computer, Intel, Alibaba And CVS Are Among Top 13 Large-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio? ↗

February 16, 2025

In the last week, these 13 large-cap stocks were top performers. Are they in your portfolio? HIMS, AUR, APP, SMCI, TEM, DKNG, INTC, MNDY, BROS, CVS, BABA, AAPL, ABNB.

Via Benzinga

Stocks Brush Off Global Trade Tensions, PPI Data ↗

February 13, 2025

Stocks are firmly higher today, despite rising global trade tensions and another hotter-than-expected inflation reading.

Via Talk Markets

Topics Economy Stocks / Equities World Trade

Hims & Hers Health Unusual Options Activity For February 10 ↗

February 10, 2025

Via Benzinga

Hims & Hers Health Unusual Options Activity ↗

February 07, 2025

Via Benzinga

Hims & Hers Health Unusual Options Activity For February 03 ↗

February 03, 2025

Via Benzinga

Robinhood, Gilead Sciences, Crocs, Lincoln Electric, HubSpot, GE HealthCare And Other Big Stocks Moving Higher On Thursday ↗

February 13, 2025

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

February 12, 2025

Via Benzinga

Why Hims & Hers Terrifies Big Pharma ↗

February 12, 2025

Big pharma tried to stop Hims & Hers' Super Bowl ad.

Via The Motley Fool

GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends

February 12, 2025

GLP-1 weight loss drugs are in short supply enabling lab to make compounded GLP-1 treatments sold for 80% less than the name-brand drugs.

Via MarketBeat

Unlocking the Growth Potential of NYSE:HIMS. ↗

January 31, 2025

A fundamental analysis of (NYSE:HIMS): Is HIMS & HERS HEALTH INC (NYSE:HIMS) suited for growth investing?

Via Chartmill

Is Hims & Hers Health Stock a Buy? ↗

January 28, 2025

Here's a look into one of healthcare's hottest growth stocks.

Via The Motley Fool

Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today ↗

February 10, 2025

Via The Motley Fool

Super Bowl Commercials 2025: Complete List of Super Bowl LIX Ads And Companies Behind Them ↗

February 10, 2025

The list of Super Bowl LIX commercials and the companies behind the Super Bowl ads.

Via Benzinga

Hims & Hers Takes Aim At Big Pharma In Controversial Super Bowl Ad — Retail Loves The Fight ↗

February 10, 2025

The commercial aired Sunday night on Fox and positioned obesity as "America's deadliest epidemic" while criticizing the $160 billion weight-loss industry and the broader healthcare system.

Via Stocktwits

Hims & Hers Health Unusual Options Activity ↗

January 21, 2025

Via Benzinga

Why the high growth investor may take a look at NYSE:HIMS. ↗

January 20, 2025

Unlocking the high Growth Potential of HIMS & HERS HEALTH INC (NYSE:HIMS).

Via Chartmill

US Stocks To Open On A Positive Note After A String Of Bad Mondays: Recent Dip Has 'Reached Its Low Point,' Says Technical Analyst ↗

February 10, 2025

U.S. stock futures rose on Monday following Friday's sharp fall as investors digest tariff updates and earnings reports.

Via Benzinga

Topics World Trade

IBD 50 Stock Hims & Hers Faces Backlash Over Provocative Super Bowl Ad ↗

February 07, 2025

Shares rocketed on Friday, but the company might not be out of hot water yet.

Via Investor's Business Daily

EXCLUSIVE: Is Super Bowl $7M Ad Cost Worth It? 61% Say No, 18% Say They Looked Up Companies After Last Year's NFL Championship ↗

February 07, 2025

Benzinga readers pick whether a $7 million Super Bowl cost is worth it for companies and how likely they are to look up a company that may be new to them after the big game.

Via Benzinga

Super Bowl LIX Commercials: AI, Celebs, Muppets, Warren Buffett-Linked Brand Take The Spotlight ↗

February 07, 2025

A list of Super Bowl LIX commercials and the celebrities and athletes attached to star in the ads.

Via Benzinga

Topics Artificial Intelligence

We Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug Wars ↗

February 07, 2025

Lilly’s fiercest competitor in the obesity market is Novo Nordisk, which offers Ozempic and Wegovy. However, rising threats from other players such as Hims & Hers, Amgen, and Viking Therapeutics also...

Via Stocktwits

Hims & Hers Launches Health Collective and Community Member Council

February 04, 2025

From Hims & Hers

Via Business Wire

Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025

February 03, 2025

From Hims & Hers

Via Business Wire

Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio? ↗

February 02, 2025

Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkable 106.57% surge following positive clinical trial results and other companies like Surgery Partners...

Via Benzinga

Ultrasound Weight Loss: GE HealthCare and Novo Nordisk’s Play

January 22, 2025

GLP-1 drugs have been all the rage for weight loss, but GE Healthcare and Novo Nordisk are working on a non-invasive approach to controlling metabolic functions

Via MarketBeat

8 Health Care Stocks Whale Activity In Today's Session ↗

January 20, 2025

Via Benzinga

Hims & Hers Health: A Stock to Trade or Own?

January 20, 2025

HIMS achieved remarkable growth in 2024 but now faces challenges in 2025, raising the question of whether it suits traders better than long-term investors.

Via MarketBeat

Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today ↗

January 17, 2025

Via The Motley Fool

< Previous 1 2

...

29 30 31 32 33 34 35 36 37

...

53 54 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.